Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 9.6B | 9.2B | 8.3B |
Cost of revenue | 6.9B | 5.9B | 6.2B | 5.5B |
Gross profit | 2.4B | 3.7B | 3.0B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.7B | 2.0B | 1.6B | 1.9B |
Other operating expenses | — | — | — | — |
Operating income | 682M | 1.7B | 1.3B | 869M |
Non operating interest income | ||||
Income | — | 93M | 83M | 98M |
Expense | 137M | 127M | 129M | 130M |
Other income expense | — | -297M | -68M | 111M |
Pretax income | 545M | 1.6B | 1.1B | 850M |
Tax provision | 154M | 216M | 326M | 295M |
Net income | 407M | 1.7B | 856M | 603M |
Basic EPS | — | 1.3 | 0.6 | 0.5 |
Diluted EPS | — | 1.3 | 0.6 | 0.5 |
Basic average shares | — | 67.7M | 67.9M | 68.1M |
Diluted average shares | — | 67.9M | 68.1M | 68.3M |
EBITDA | 1.0B | 2.1B | 1.8B | 1.3B |
Net income from continuing op. | 407M | 1.7B | 856M | 603M |
Minority interests | -5M | -3M | -3M | -2M |
Preferred stock dividends | — | — | — | — |